Follow
Jiatong Li
Jiatong Li
Other namesLi Jiatong
Shanghai Cancer Research Institute
Verified email at renji.com
Title
Cited by
Cited by
Year
HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial–mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin …
W Tian, J Li, Z Wang, T Zhang, Y Han, Y Liu, W Chu, Y Liu, B Yang
Acta Pharmaceutica Sinica B 11 (6), 1592-1606, 2021
342021
Pancreatic cancer environment: from patient-derived models to single-cell omics
A Gu, J Li, S Qiu, S Hao, ZY Yue, S Zhai, MY Li, Y Liu
Molecular Omics 20 (4), 220-233, 2024
222024
Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications
J Li, A Gu, XM Nong, S Zhai, ZY Yue, MY Li, Y Liu
The Chemical Record 23 (12), e202300293, 2023
162023
Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications
MY Li, S Zhai, XM Nong, A Gu, J Li, GQ Lin, Y Liu
Science China Chemistry 66 (5), 1261-1287, 2023
122023
1, 3-diene-based AIEgens: Stereoselective synthesis and applications
XM Nong, A Gu, S Zhai, J Li, ZY Yue, MY Li, Y Liu
Iscience, 2024
62024
Solvent-free and catalyst-free direct alkylation of alkenes
MY Li, J Li, A Gu, XM Nong, S Zhai, ZY Yue, CG Feng, Y Liu, GQ Lin
Green Chemistry 25 (18), 7073-7078, 2023
62023
Heteroaryl Group Containing Trisubstituted Alkenes: Synthesis and Anti‐tumor Activity
J Li, A Gu, MY Li
Chemistry & Biodiversity, e202401469, 0
3
Exploration of Dan-Shen-Yin against pancreatic cancer based on network pharmacology combined with molecular docking and experimental validation
A Gu, J Li, JA Wu, MY Li, Y Liu
Current Research in Biotechnology, 100228, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–8